Germany’s Bundesrat (Federal Council) has voted to pass the CanG bill without calling in a mediation committee, meaning the law should come into effect on… Read More »Germany Passes Landmark Cannabis Bill: Law Set To Come In On 01/04/2024

Post-traumatic stress disorder (PTSD) may occur in people who have experienced a traumatic event. People with PTSD have intense, disturbing thoughts and feelings related to their experience… Read More »PTSD in medical cannabis access schemes

Brains Bioceutical Corp (“Brains Bio” or the “Company”), Brains Bio, a pioneer in the cannabinoid-based pharmaceutical industry, is proud to announce a significant breakthrough in… Read More »Brains Bioceutical Corp’s Solid THC Paves the Way for Revolutionary Drug Development for the pharmaceutical industry

Exclusive cultivation areas and services are already available for more than 500 cannabis clubs. The subsidiary of Cannovum Cannabis AG, Anbau-Allianz für Deutschland GmbH, offers… Read More »Areas For More Than 500 Cannabis Clubs Available Amid Argricultural Partnership

In a milestone moment for European cannabis, Germany has officially passed its cannabis bill following months of intense debate and a number of holdups. Germany’s… Read More »Germany’s Cannabis Bill Passes With Large Majority

Curaleaf International has acquired Polish medical cannabis operator Can4Med, giving the London-based company a foothold in one of Europe’s most promising medical marijuana markets. The financial terms… Read More »Curaleaf International acquires Polish medical cannabis company

Germany’s Cannabis Act (CanG) is entering increasingly uncertain territory as support within the coalition’s largest party crumbles, and criticism of the bill begins to surface… Read More »Crumbling SPD Support Threatens Future of Germany’s CanG Bill

The general authorisation of medical cannabis has moved a step closer with the French government granting it temporary status for five years – and scope… Read More »Medical cannabis gets go-ahead for pain relief in French hospitals

A growing number of schemes aimed at offering industrial hemp farmers an additional and potentially significant revenue stream through the issuance of carbon credits have… Read More »Are ‘Milestone’ Initiatives Set to ‘Unlock the Potential of Hemp’ For UK Economy & Climate?

The maker of CBD prescription drug Epidiolex has filed a lawsuit in the USA alleging patent infringement. GW Research Ltd, a subsidiary of Ireland-based Jazz… Read More »Epidiolex maker files suit in U.S. to protect its patents